For decades, India has earned global recognition as the "Pharmacy of the World," supplying affordable generic medicines and vaccines to millions across the globe. Today, however, the country's pharmaceutical industry is undergoing a significant transformation. As healthcare systems increasingly adopt biologics, biosimilars, cell therapies, and precision medicine, India is preparing for a new manufacturing era-one that demands far greater technological sophistication than conventional pharmaceutical production.

At the heart of this shift is a growing need for advanced bioprocessing infrastructure, an area where Pune-based PharmNXT Biotech is building its presence.